Non-Narcotic Pain Management Technology, Making Its Way to the Market

There is another groundbreaking invention forcing itssince the start of its sales in February last year. But a
way to the market. There may be new hope forfew days ago, improvements have started to take
those patients who typically have not responded toplace. Investors who were disappointed with the last
any treatment protocol performed in accordance withyear of sales have now been given a light of hope.
Multidrug Therapy (MDT), or surface electro-stimulation.In the present, there are lots of studies that are
A new pain relief therapy has been discovered and isconducted to test the effectiveness of the said
proven by clinical studies as effective and has beentherapy. They are expected to present their patient
cleared by the DFA. The new device that is used is acase studies that will either approve or disprove the
non-invasive, non-narcotic method for treatment ofeffectiveness of their non-narcotic approach to treat
severe, chronic, high-intensity oncologic and neuropathicsevere pain from cancer, chemotherapy-induced
pain, which is resistant to morphine and other drugs.peripheral neuropathy (CIPN), failed back surgery,
This therapy does not use a biochemical but rather thephantom limb syndrome, pain from shingles and other
biophysical process. With continuous therapy, painkinds of chronic pain. A success in the clinical study
gradually lessens and eventually disappears in a highabout the effectiveness of the therapy to treat
percentage of cases. The device utilizes the electricalChemotherapy-induced peripheral neuropathy may
impulses instead of narcotic painkillers. These arewarrant a peer-reviewed article that will be published in
intended for patients who suffer chronic pain, especiallya medical journal. This will surely bring the product to its
to those who do not respond to narcotic painkillers.rise.
Commonly, these people suffer consistent pain andToday, the product is not sold to the United States but
are not responsive even to high doses and powerfulIn Virginia, there is a study conducted to assess the
narcotic drugs. Chronic pain therapy is a multi-billioneffectiveness of the said technology. If the studies will
dollar industry with anticipated thousands of patientssupport what is claimed, the sales may be increased
frustrated to unleash themselves from ineffectiveand consequently, more investors may be attracted
drugs and their accompanying side effects.and an increased supply may surely follow.
The sad part is that the business seems to be a failure